HKEX Shareholding Disclosures on November 20

Stock News11-20

KINTOR PHARMA-B (09939), SHENZHENEXPRESS (00548), GUSHENGTANG (02273), and YSB (09885) disclosed their latest shareholding changes on November 20, 2025.

**KINTOR PHARMA-B (09939)** - **Tong Youzhi**: Increased long position from 51.5003 million shares to 52.2003 million shares (11.15% latest vs. 11.00% previous). - **KT International Investment Limited**: Increased long position from 49.0003 million shares to 49.7003 million shares (10.62% latest vs. 10.47% previous).

**SHENZHENEXPRESS (00548)** - **Jiangsu Yunshan Capital Management Co., Ltd.**: Increased long position from 74.7500 million shares to 82.2260 million shares (11.00% latest vs. 10.00% previous). - **Jiangsu Communications Holding Co., Ltd.**: Increased long position from 74.7500 million shares to 82.2260 million shares (11.00% latest vs. 10.00% previous).

**GUSHENGTANG (02273)** - **Action Thrive Group Limited**: Increased long position from 30.0274 million shares to 30.1334 million shares (13.01% latest vs. 12.97% previous). - **Tu Zhiliang**: Increased long position from 81.3736 million shares to 81.4796 million shares (35.19% latest vs. 35.14% previous).

**YSB (09885)** - **Chen Fei**: Increased long position from 8.6000 million shares to 8.8000 million shares (1.29% latest vs. 1.26% previous).

*Note: Shareholding changes may result from rights issues, share consolidations, or splits. Please verify against actual circumstances.*

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment